NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT04067960 2024-08-14Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerMayo ClinicPhase EARLY_PHASE1 Completed197 enrolled